miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia
Authors:
- Valeria ManziniVMValeria Manzini
- Pamela CappellettiPCPamela Cappelletti
- Nicola S. OreficeNONicola S. Orefice
- Ilaria BrentariIBIlaria Brentari
- Michael J. RigbyMRMichael J. Rigby
- Maria Lo GiudiceMGMaria Lo Giudice
- Marco FeligioniMFMarco Feligioni
- Roberto RivabeneRRRoberto Rivabene
- Alessio CrestiniAlessio Crestini
- Francesco ManfrediFrancesco Manfredi
- Giuseppina TalaricoGTGiuseppina Talarico
- Giuseppe BrunoGBGiuseppe Bruno
Open Access
- 14 August 2024
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (2) , 2573-2586
Abstract
Despite the efforts to identify fluid biomarkers to improve diagnosis of Frontotemporal dementia (FTD), only a few candidates have been described in recent years. In a previous study, we identified three circulating miRNAs (miR-92a-3p, miR-320a and miR-320b) differentially expressed in FTD patients with respect to healthy controls and/or Alzheimer’s disease (AD) patients. Now, we investigated whether those changes could be due to miRNAs contained in neuron-derived extracellular vesicles (NDEVs). We also evaluated miRNAs content in total plasma EVs and in CSF samples. The analysis of plasma NDEVs carried out on 40 subjects including controls (n = 13), FTD (n = 13) and AD (n = 14) patients, showed that both miR-92a-3p and miR-320a levels were triplicated in the FTD group if compared with CT and AD patients. Increased levels of the same miRNAs were found also in CSF derived from FTD group compared to CTs. No differences were observed in expression levels of miR-320b among the three groups. Worthy of note, all miRNAs analysed were increased in an FTD cell model, MAPT IVS10 + 16 neurons. Our results suggest that miR-92a and miR-320a in NDEVs could be proposed as FTD biomarkers.Keywords
Funding Information
- Fondazione Valorizzazione Ricerca Trentina; University of Trento (AB32 CUP I85H20000200005)
- Istituto Superiore di Sanità (BFC1)
- Università degli Studi di Trento
This publication has 70 references indexed in Scilit:
- The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid β deposition in the brain of patients with Alzheimer’s diseaseClinical Biochemistry, 2023
- Precise profiling of exosomal biomarkers via programmable curved plasmonic nanoarchitecture-based biosensor for clinical diagnosis of Alzheimer's diseaseBiosensors and Bioelectronics, 2023
- Dysregulated miRNAs in Progression and Pathogenesis of Alzheimer’s DiseaseMolecular Neurobiology, 2022
- New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementiaAlzheimer's & Dementia, 2022
- Identification of miRNAs Bound to an RNA of Interest by MicroRNA Capture Affinity Technology (miR-CATCH)2021
- Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injuryBiochemical Pharmacology, 2021
- Circulating exosomal MicroRNAs: New non-invasive biomarkers of non-communicable diseaseMolecular Biology Reports, 2020
- Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2016
- Non-coding RNAs in Alzheimer's DiseaseMolecular Neurobiology, 2012
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011